# FDA Inspection 1194222 - New York Blood Center, Inc. - December 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/c76cf2c4-354e-4d81-8fe6-6cb1edadedaf
Source feed: FDA_Inspections

> FDA Inspection 1194222 for New York Blood Center, Inc. on December 19, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194222
- Company Name: New York Blood Center, Inc.
- Inspection Date: 2022-12-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194222 - 2022-12-19](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/183ae647-d4a8-4cdc-b593-b61163e1247d)
- [FDA Inspection 1094266 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/b093e647-c51a-46f5-a09d-7f031a9988c9)
- [FDA Inspection 1009901 - 2017-04-25](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/66cf5024-46e1-4891-8fa0-827452bf824a)
- [FDA Inspection 903225 - 2014-11-07](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/6b626cfb-b85c-4280-88d6-867dfd2739a1)
- [FDA Inspection 831324 - 2013-05-10](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/8f09ecba-1299-41fb-8dcc-810a9147204d)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/53394ccb-066a-4961-824a-b14316f7d768

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d